Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. The average EVD case fatality rate is around 50%.

The virus first appeared in 1976 in two simultaneous outbreaks, one in Nzara, Sudan, and the other in Yambuku, Democratic Republic of Congo. The latter occurred in a village near the Ebola River, from which the disease takes its name.

The 2014 outbreak in West Africa is the largest and most complex Ebola outbreak since the virus was first discovered. There have been more cases and deaths in this outbreak than all others combined.

Infection Control is Crucial

In the absence of an effective treatment, infection control is crucial in order to avoid further transmission of the disease.

The virus is classified as Risk Group 4 (highest safety level) and is what is known as an “enveloped virus.”

Enveloped Viruses

Enveloped viruses like Ebola are easier to destroy than non-enveloped viruses. Some disinfectants based on advanced microbial control technology active ingredients show efficacy against both enveloped and non-enveloped types.

Although there are no products with specific label claims against the Ebola virus, enveloped viruses like Ebola are known to be susceptible to a broad range of hospital disinfectants used to disinfect hard, non-porous surfaces.